← Leaderboards
Kiran Kaur Khush
Stanford University
$5,140,538
Attributed
$6,616,831
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2009–23$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,616,831 · 3
By mechanism
R01$5,942,500 · 2
K23$674,331 · 1
Top collaborators
- Arash Ash Alizadeh5 shared
Most similar at Stanford University
Same institution · by research overlap
- Minnie M Sarwal$8,971,142
- Maximilian Diehn$12,346,945
- Douglas K Owens$18,351,765
- Oscar Salvatierra$7,752,493
- Chao Zhang$2,107,999
Others in their field
Top investigators on “Transplant Recipients”
- Leland H Hartwell · Fred Hutchinson Cancer Research Center$84,240,435
- Peter Scott Heeger · Case Western Reserve University$83,635,934
- Joren C Madsen · Massachusetts General Hospital$58,876,734
- Mary M Horowitz · Medical College Of Wisconsin$55,693,586
- Peter G Stock · University Of California San Francisco$39,243,787
- Leslie S Kean · Emory University$39,217,487
Research focus
Transplant RecipientsTransplantationVariantInnovationBaseDesignSamplingHeart TransplantationUniversitiesTherapeutic ImmunosuppressionPatient PopulationCohortPerformanceAllograftingInvestigationHypertensionAffectHospitalizationLeft Ventricular DysfunctionBrain Natriuretic PeptideCause Of DeathHeartGraft FunctionFunctional Disorder
Grant awards (15)
A Noninvasive Integrated Genomic Approach for Early Cancer Detection and Risk Stratification after Transplantation$563,780
R01 · FY2023 · CA · contact PI
A Noninvasive Integrated Genomic Approach for Early Cancer Detection and Risk Stratification after Transplantation$563,780
R01 · FY2022 · CA · contact PI
A Noninvasive Integrated Genomic Approach for Early Cancer Detection and Risk Stratification after Transplantation$600,639
R01 · FY2021 · CA · contact PI
A Noninvasive Integrated Genomic Approach for Early Cancer Detection and Risk Stratification after Transplantation$606,977
R01 · FY2020 · CA · contact PI
A Noninvasive Integrated Genomic Approach for Early Cancer Detection and Risk Stratification after Transplantation$617,410
R01 · FY2019 · CA · contact PI
Evidence Based Evaluation and Acceptance of Donor Hearts for Transplantation$565,012
R01 · FY2019 · HL · contact PI
Evidence Based Evaluation and Acceptance of Donor Hearts for Transplantation$565,012
R01 · FY2018 · HL · contact PI
Evidence Based Evaluation and Acceptance of Donor Hearts for Transplantation$565,012
R01 · FY2017 · HL · contact PI
Evidence Based Evaluation and Acceptance of Donor Hearts for Transplantation$565,448
R01 · FY2016 · HL · contact PI
Evidence Based Evaluation and Acceptance of Donor Hearts for Transplantation$729,430
R01 · FY2015 · HL · contact PI
Clinical and Genetic Evaluation of Donors for Cardiac Transplantation$134,884
K23 · FY2013 · HL · contact PI
Clinical and Genetic Evaluation of Donors for Cardiac Transplantation$134,884
K23 · FY2012 · HL · contact PI
Clinical and Genetic Evaluation of Donors for Cardiac Transplantation$134,884
K23 · FY2011 · HL · contact PI
Clinical and Genetic Evaluation of Donors for Cardiac Transplantation$134,854
K23 · FY2010 · HL · contact PI
Clinical and Genetic Evaluation of Donors for Cardiac Transplantation$134,825
K23 · FY2009 · HL · contact PI